Log In
BCIQ
Print this Print this
 

ATM AVI, ATM-AVI

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCombination of aztreonam and avibactam antibiotics
Molecular Target Beta lactamase (LACTB)
Mechanism of ActionBeta lactamase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat Gram-negative bacterial infection
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,575.0M

$725.0M

$850.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/24/2016

$1,575.0M

$725.0M

$850.0M

12/29/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today